"As the Company works towards finalizing a definitive agreement with respect to Brilacidin for Ulcerative Proctitis (UP)/Ulcerative Proctosigmoiditis (UPS), "
We never heard anything like that regarding the August 2018 Term Sheet.
It appears that IPIX wants THIS deal and now wants to "cement it".
Kelt
(11)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links